prof. dr. E.G.E. (Elisabeth) de Vries


No picture available


  1. 1999
  2. Vellenga, E., Muller, M., & de Vries, EGE. (1999). Multidrug resistance protein MRP1, glutathione, and related enzymes - Their importance in acute myeloid leukemia. In GJL. Kaspers, R. Pieters, & AJP. Veerman (Eds.), DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III (pp. 187-198). (ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY; Vol. 457). NEW YORK: Kluwer Academic/Plenum Publishers.
  3. 1998
  4. Jager, PL., Franssen, EJF., Kool, W., Szabo, BG., Hoekstra, HJ., Groen, HJM., ... Piers, DA. (1998). Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. Journal of Nuclear Medicine, 39(10), 1736-1743.
  5. Mourits, MJE., de Vries, EGE., Willemse, PHB., ten Hoor, KA., Hollema, H., de Bruijn, HWA., & van der Zee, HWA. (1998). Is ovarian cyst formation related to tamoxifen use? European Journal of Cancer, 34, S21-S22.
  6. Hendrikse, NH., Franssen, EJF., van der Graaf, WTA., Meijer, C., Piers, DA., Vaalburg, W., & de Vries, EGE. (1998). Tc-99m-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. British Jounal of Cancer, 77(3), 353-358.
  7. de Vries, EGE., Meijs, PJM., & Rodenhuis, S. (1998). Third-party payers and breast cancer study. Journal of Clinical Oncology, 16(2), 809-809.
  8. de Bruijn, HWA., Duk, JM., van der Zee, AGJ., Pras, E., Willemse, PHB., Hollema, H., ... Boonstra, J. (1998). The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. TUMOR BIOLOGY, 19(6), 505-516.
  9. Schroder, CP., van der Graaf, WTA., Willemse, PHB., Vellenga, E., de Leij, L., Mulder, NH., & de Vries, EGE. (1998). The impact of haematopoietic growth factors on supportive care in clinical oncology: With special attention to potential tumour cell contamination in the stem cell harvest. In CTS. Sibinga, PC. Das, & JC. Fratantoni (Eds.), ALTERNATIVE APPROACHES TO HUMAN BLOOD RESOURCES IN CLINICAL PRACTICE (pp. 81-95). (DEVELOPMENTS IN HEMATOLOGY AND IMMUNOLOGY; Vol. 33). DORDRECHT: Springer.
  10. 1997
  11. Bakker, M., Renes, J., Groenhuijzen, A., Visser, P., TimmerBosscha, H., Muller, M., ... deVries, EGE. (1997). Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines. International Journal of Cancer, 73(3), 362-366.
  12. Hofstra, LS., deVries, EGE., & Willemse, PHB. (1997). Ophthalmic toxicity following paclitaxel infusion. Annals of Oncology, 8(10), 1053-1053.
  13. Brada, SJL., Wijffels, RTM., Kahraman, T., & deVries, EGE. (1997). Sublingual nitrate provides cause for fear of food in a carcinoid patient. Annals of Oncology, 8(10), 1053-1054.
  14. Hofstra, LS., vanderGraaf, WTA., deVries, EGE., HaaxmaReiche, H., & Willemse, PHB. (1997). Ataxia following docetaxel infusion. Annals of Oncology, 8(8), 812-813.
  15. deJong, RS., Hofstra, LS., Willemse, PHB., deBruijn, HWA., deVries, EGE., Mulder, NH., & Boonstra, J. (1997). Effect of low-dose oral etoposide on serum CA-125 in patients with advanced epithelial ovarian cancer. Gynecologic Oncology, 66(2), 197-201.
  16. deVries, EGE., Mastenbroek, CC., & Rodenhuis, S. (1997). High-dose chemotherapy for breast cancer - To the editor. Annals of Internal Medicine, 126(11), 917-918.

ID: 162081